Radiopharm Theranostics Secures Ethics Approval to Expand Phase 1 Cancer Trial; Shares Up 4%

MT NewswiresNov 19 12:07

Radiopharm Extends Radioimmunotherapy Trial to 5 More Cancer Types

The Market HeraldNov 19 11:55

Radiopharm Theranostics Teams Up With AtomVie Global Radiopharma for Antibody Development; Shares Up 4%

MT NewswiresOct 16 09:41

Radiopharm Theranostics Ltd: ESG Report

ASXSep 30 14:42 · Announcements

Radiopharm Theranostics Ltd: Annual Report

ASXSep 30 14:27 · Announcements

Radiopharm Theranostics Ltd: Appendix 4E and Preliminary Final Report

Aug 30 07:53 · Announcements